Your session is about to expire
← Back to Search
Electrical Stimulation
Brain & Muscle Stimulation for Stroke Rehabilitation
N/A
Recruiting
Led By David A Cunningham, PhD
Research Sponsored by MetroHealth Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Full volitional elbow extension/flexion and hand opening/closing of unaffected limb
Able to follow 3-stage commands and remember 2 of 3 items after 30 minutes
Must not have
Severe shoulder or hand pain (unable to position hand in the workspace without pain)
Uncontrolled seizure disorder
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to one hour post intervention
Awards & highlights
Summary
This trialwill study how electrical brain and muscle stimulation may improve hand movement in stroke patients with paralysis.
Who is the study for?
This trial is for stroke survivors over 21 years old with chronic upper limb hemiplegia, who can follow commands and have some finger movement. They must be medically stable, able to sit unassisted, and at least 6 months post-stroke. Excluded are pregnant individuals, those with other neurological conditions or severe pain in the affected limb, recent botox injections in the arm muscles, certain metal implants or electronic devices.
What is being tested?
The study tests how non-invasive brain stimulation (tDCS) combined with functional electrical stimulation affects hand motor control in stroke patients. It explores optimal timing and delivery methods of these treatments to improve hand function.
What are the potential side effects?
Potential side effects may include discomfort at the stimulation site on the scalp or skin irritation from electrodes used during electrical stimulation. There's also a small risk of seizure due to brain stimulation but precautions are taken to minimize this.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can fully move and use my unaffected arm and hand.
Select...
I can follow complex instructions and remember things well.
Select...
I do not have major issues with my sight or hearing.
Select...
My skin is unbroken on my weaker side's arm, hand, and head.
Select...
I can sit by myself in a chair without arms for the needed time.
Select...
I can move my shoulder and elbow enough to use my hand for table-top tasks.
Select...
I can extend my fingers at least 10 degrees.
Select...
I am 21 years old or older.
Select...
I have weakness in one arm and some hand movement ability.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I cannot move my hand or shoulder without severe pain.
Select...
I have seizures that are not controlled by medication.
Select...
I have a neurological condition besides a past stroke affecting my arm.
Select...
I have severe difficulties in thinking and communicating.
Select...
I have not had botox injections in my arm muscles in the last 3 months.
Select...
I cannot feel my arm, forearm, or hand.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to one hour post intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to one hour post intervention
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Corticospinal Excitability
Reaction Time
Trial Design
5Treatment groups
Experimental Treatment
Placebo Group
Group I: unconventional tDCS preceding CCFESExperimental Treatment1 Intervention
tDCS cathode placed over the lesioned hemisphere and anode placed over the non-lesioned hemisphere
Group II: unconventional tDCS concurrent with CCFESExperimental Treatment1 Intervention
tDCS cathode placed over the lesioned hemisphere and anode placed over the non-lesioned hemisphere
Group III: conventional tDCS preceding CCFESExperimental Treatment1 Intervention
tDCS anode placed over the lesioned hemisphere and cathode placed over the non-lesioned hemisphere
Group IV: conventional tDCS concurrent with CCFESExperimental Treatment1 Intervention
tDCS anode placed over the lesioned hemisphere and cathode placed over the non-lesioned hemisphere
Group V: sham tDCS with CCFESPlacebo Group1 Intervention
sham tDCS preceding and concurrent with CCFES
Find a Location
Who is running the clinical trial?
MetroHealth Medical CenterLead Sponsor
115 Previous Clinical Trials
21,293 Total Patients Enrolled
David A Cunningham, PhDPrincipal InvestigatorMetroHealth Medical Center
1 Previous Clinical Trials
63 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I can fully move and use my unaffected arm and hand.I can follow complex instructions and remember things well.I do not have major issues with my sight or hearing.Electrical stimulation helps open my hand without pain.My skin is unbroken on my weaker side's arm, hand, and head.I can sit by myself in a chair without arms for the needed time.I can move my shoulder and elbow enough to use my hand for table-top tasks.I cannot move my hand or shoulder without severe pain.I can extend my fingers at least 10 degrees.I have seizures that are not controlled by medication.I have a neurological condition besides a past stroke affecting my arm.I have severe difficulties in thinking and communicating.I am 21 years old or older.You have a metal implant in your head.I have not had botox injections in my arm muscles in the last 3 months.You have difficulties paying attention to things on one side of your body.It has been over 6 months since my last stroke.Dr. Wilson approves of my seizure medication.I have weakness in one arm and some hand movement ability.You have a pacemaker, implanted electronic device, or stent in your heart.I cannot feel my arm, forearm, or hand.
Research Study Groups:
This trial has the following groups:- Group 1: conventional tDCS concurrent with CCFES
- Group 2: conventional tDCS preceding CCFES
- Group 3: unconventional tDCS preceding CCFES
- Group 4: sham tDCS with CCFES
- Group 5: unconventional tDCS concurrent with CCFES
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger